Phase 1 Dose- Escalation Trial of Clofarabine Followed by Escalating Dose of Fractionated Cyclophosphamide in Adults with Relapsed or Refractory Acute Leukaemias

The prognosis of patients with relapsed and refractory acute leukaemia (RRAL) is very poor. Forty patients with RRAL were enrolled (28 acute myeloid leukaemia [AML], 12 acute lymphoblastic leukaemia [ALL]) in this Phase 1 dose-escalation trial of daily-infused clofarabine (CLO) followed by cyclophos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zeidan, Amer M, Ricklis, Rebecca M, Carraway, Hetty E, Yun, Hyun D, Greer, Jacqueline M, Smith, B Douglas, Levis, Mark J, McDevitt, Michael A, Pratz, Keith W, Showel, Margaret M, Gladstone, Douglas E, Gore, Steven D, Karp, Judith E
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3389586/
https://ncbi.nlm.nih.gov/pubmed/22594769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2012.09142.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars